Hartung Odelya, Huo Hongguang, Daley George Q, Schlaeger Thorsten M
Stem Cell Program, Children's Hospital Boston, Boston, Massachusetts, USA.
Curr Protoc Stem Cell Biol. 2010 Aug;Chapter 1:Unit 1C.10. doi: 10.1002/9780470151808.sc01c10s14.
The ability of human embryonic stem cells (hESCs) to differentiate into essentially all somatic cell types has made them a valuable tool for studying human development and has positioned them for broad applications in toxicology, regenerative medicine, and drug discovery. This unit describes a protocol for the large-scale expansion and maintenance of hESCs in vitro. hESC cultures must maintain a balance between the cellular states of pluripotency and differentiation; thus, researchers must use care when growing these technically demanding cells. The culture system is based largely on the use of a proprietary serum-replacement product and basic fibroblast growth factor (bFGF), with mouse embryonic fibroblasts as a feeder layer. These conditions provide the basis for relatively inexpensive maintenance and expansion of hESCs, as well as their engineered counterparts, human induced pluripotent stem cells (hiPSCs).
人类胚胎干细胞(hESCs)能够分化为几乎所有的体细胞类型,这使其成为研究人类发育的宝贵工具,并为其在毒理学、再生医学和药物发现等领域的广泛应用奠定了基础。本单元介绍了一种在体外大规模扩增和维持hESCs的方案。hESC培养必须在多能性和分化的细胞状态之间保持平衡;因此,研究人员在培养这些技术要求较高的细胞时必须格外小心。该培养系统主要基于使用一种专利血清替代产品和碱性成纤维细胞生长因子(bFGF),并以小鼠胚胎成纤维细胞作为饲养层。这些条件为相对廉价地维持和扩增hESCs及其工程对应物——人类诱导多能干细胞(hiPSCs)提供了基础。